港股異動 | 中滙集團(0382.HK)直線拉昇漲超4% 午間發佈上市後第三次盈喜
格隆匯9月10日丨粵港澳大灣區最大的民辦商科高等教育集團中滙集團(0382.HK)午後直線拉昇,現報5.8港元,漲4.13%,暫成交1228萬港元,最新總市值59億港元。中滙集團今日午間發公告稱,預期集團於截至今年8月31日止年度所錄得核心純利較去年同期增加不少於30%。受惠於國家政策支持大灣區發展以及大灣區對商科人才的迫切需求等利好,中滙集團2019/20學年學生人數及平均學費齊升,2020/21學年新生學費錄得可觀增長。中泰國際曾發研報稱,預計公司未來三年淨利潤可以保持同比增長23%-30%,按照2021財年的20倍PE將目標價從7.1港元上調至7.7港元,維持“買入”評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.